HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiuwei H Yang Selected Research

Integrins

6/2021CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.
4/2021The Context-Dependent Impact of Integrin-Associated CD151 and Other Tetraspanins on Cancer Development and Progression: A Class of Versatile Mediators of Cellular Function and Signaling, Tumorigenesis and Metastasis.
12/2020BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways.
1/2020Integrin-associated CD151 is a suppressor of prostate cancer progression.
1/2020Epigenetic Input Dictates the Threshold of Targeting of the Integrin-Dependent Pathway in Non-small Cell Lung Cancer.
1/2019The metastasis suppressor NME1 inhibits melanoma cell motility via direct transcriptional induction of the integrin beta-3 gene.
10/2015CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.
12/2014CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling.
8/2012Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.
3/2010Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiuwei H Yang Research Topics

Disease

16Neoplasms (Cancer)
06/2023 - 05/2006
8Neoplasm Metastasis (Metastasis)
03/2023 - 08/2012
6Breast Neoplasms (Breast Cancer)
12/2020 - 05/2008
4Carcinogenesis
04/2021 - 08/2012
2Ovarian Neoplasms (Ovarian Cancer)
03/2023 - 12/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2021 - 01/2020
2Glioblastoma (Glioblastoma Multiforme)
04/2021 - 10/2015
2Melanoma (Melanoma, Malignant)
01/2019 - 06/2015
1Carcinoma (Carcinomatosis)
04/2021
1Triple Negative Breast Neoplasms
12/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Adenocarcinoma
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
05/2016
1Colonic Neoplasms (Colon Cancer)
05/2016
1Nevus (Nevi)
06/2015
1Ascites
12/2014

Drug/Important Bio-Agent (IBA)

11IntegrinsIBA
06/2021 - 05/2008
8TetraspaninsIBA
06/2021 - 05/2006
7Proteins (Proteins, Gene)FDA Link
06/2021 - 05/2006
5Messenger RNA (mRNA)IBA
01/2020 - 06/2015
3Biomarkers (Surrogate Marker)IBA
01/2020 - 10/2015
2Phosphotransferases (Kinase)IBA
03/2023 - 03/2010
2defactinibIBA
12/2020 - 01/2020
2CateninsIBA
12/2019 - 05/2016
2Ethanol (Ethyl Alcohol)IBA
05/2016 - 01/2016
2Epidermal Growth Factor (EGF)IBA
10/2015 - 08/2012
1demethylzeylasteralIBA
06/2023
1Antineoplastic Agents (Antineoplastics)IBA
06/2023
1SincalideFDA Link
06/2023
1Terpenes (Terpenoids)IBA
06/2023
1tyrosine receptor (receptor, tyrosine)IBA
03/2023
1matrigelIBA
06/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2021
1PlasticsIBA
04/2021
1Protein Kinases (Protein Kinase)IBA
12/2020
1Histone Deacetylases (Histone Deacetylase)IBA
01/2020
1adhesion receptorIBA
01/2020
1PanobinostatIBA
01/2020
1Cadherins (E-Cadherin)IBA
01/2020
1Focal Adhesion Protein-Tyrosine KinasesIBA
01/2020
1Phenobarbital (Luminal)FDA Link
12/2019
1Cyclin D1IBA
12/2019
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2016
1ChemokinesIBA
05/2016
1Monomeric GTP-Binding ProteinsIBA
10/2015
1Fibronectins (Fibronectin)IBA
06/2015
1Deubiquitinating EnzymesIBA
10/2013
1ChromatinIBA
10/2013
1Lapatinib (GW572016)FDA Link
03/2010
1Trastuzumab (Herceptin)FDA Link
03/2010
1KalininIBA
03/2010
1Progesterone Receptors (Progesterone Receptor)IBA
05/2008
1Estrogen ReceptorsIBA
05/2008
1Laminin (Merosin)IBA
05/2008
1Integrin alpha6IBA
05/2008
1AntibodiesIBA
05/2006
1ErbB Receptors (EGF Receptor)IBA
05/2006

Therapy/Procedure

3Therapeutics
03/2023 - 01/2020
1Drug Therapy (Chemotherapy)
06/2023